The Agilus Diagnostics IPO: What You Should Be Looking For In The 2nd Largest Indian Diagnostics?

AltG INNOVATION CENTRE
Pushing The Science Of Business Forward Everyday.




Godfrey Phillips's 24SEVEN Deal: Spin-Off To Create $10 Billion Market Cap


Nirma's Glenmark Life Sciences Deal for $680 Million: Strategic Move into Pharma


Barbeque Nation: A Secret $5Billion CDR Company Taking On QSR in India


Bloomberg's TATA Assessment: Correct Conclusion, Constrained Content


2023 And Beyond: Premiumisation & Decentralisation


So Why Do We Write A Newsletter?


Decoding The Playbook For Generating Stellar Returns In India’s IPO Market


Shifting Fortunes: How Joe Biden's China Investment Ban Is Set to Propel India's Private Markets


M&M’s Investment In RBL Bank: How Not To Do Capital Allocation


Investment Tear Sheet: India's B2B Database Businesses


The Blackstone-Cipla Deal: Platforms The Holy Grail Of India Investments


India's Missing Middle 'Platforms': Unveiling the Untapped Goldmine That Could Change Everything!


Decoding AltG's Investment Criteria for Allocating a Billion Dollars In India


Indian Corporate Carve-Outs: Why Major Companies are Spinning Off to Soar to New Heights!


Venture Debt In Indian Startups: The Valley Of Death Or The Promised Land?


The Top 3 Trends Private Equity Should Be Watching in H2 2023


The PharmEasy Saga: An SOS Call and A Billionaire's Low Ball


The Great Indian Startup Sale: Offline Assets Are The Holy Grail


SENSEX vs BSE: The “Capital Allocation” Multi-Baggers